Jim Cramers Morning Meeting Highlights Market Opportunities and Risks US Sanctions Strategy Against Iran May Be Approaching Its Limits Microsofts GitHub Faces Headwinds in AI Coding Race Amid Outages and Rising Competition Puerto Ricos 2026 Tourism Outlook Old San Juan and Vieques Emerge as Key Destinations Meta Stock Declines After Quarterly Results Cite Iran Internet Disruptions Impacting User Numbers SpaceX Eyes Public Markets What Investors Should Know About the Potential IPO ASAN Q1 2026 Earnings EPS Beats Estimates as Shares Edge Lower MaxLinear Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Royal Gold Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Dominos Pizza DPZ Q1 2026 Earnings EPS Misses Consensus Stock Edges Lower Metalla Royalty Streaming Q1 2026 Earnings EPS Misses Estimates but Stock Rises 545 on Strategic Progress PAGP Q1 2026 Earnings Massive EPS Surprise Highlights Resilient Midstream Operations Evercore EVR Holds Steady Near 346 as Consolidation Continues Pelican Acquisition Corporation PELI Plunges 1179 Key Support Levels Under Scrutiny Bold Eagle Acquisition Corp BEAG Holds Steady Near 1058 as Support and Resistance Levels Come into Focus Eaton Vance Municipal Income 2028 Term Trust ETX Holds Steady Near 191 Amid Modest Uptick Jasper Therapeutics JSPR Edges Higher as Stock Tests Key Resistance Near 096 FastestGrowing ETF Leverages the AI Memory Surge Inflation Pressure Broadens Beyond Oil and Iran Consumers Face Rising Costs in Housing Food and Services Ukraine Gymnastics Federation Seeks Emergency FIG Congress Over Russian Athlete Reinstatement Fed Interest Rate Hike Expected as Soon as December Futures Markets Signal After Inflation Data Alain Prost Injured in Home Raid Safety Concerns for HighProfile Figures CLARITY Act Passage Odds Decline as Spain Blocks Prediction Markets Regulatory Uncertainty Looms Samsung Electronics Chip Division Workers Reach Tentative Deal for Record Bonuses Amid Strike Resolution NVNO Q3 2025 Earnings Narrower Net Loss Surpasses Analyst Expectations TransCode Therapeutics RNAZ Surges 2 as Biotech Stock Tests Key Resistance at 655